Annual Net Income
$414.83 M
+$638.89 M+285.14%
31 December 2023
Summary:
Jazz Pharmaceuticals annual net profit is currently $414.83 million, with the most recent change of +$638.89 million (+285.14%) on 31 December 2023. During the last 3 years, it has risen by +$176.22 million (+73.85%). JAZZ annual net income is now -20.74% below its all-time high of $523.37 million, reached on 31 December 2019.JAZZ Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
$215.06 M
+$46.49 M+27.58%
30 September 2024
Summary:
Jazz Pharmaceuticals quarterly net profit is currently $215.06 million, with the most recent change of +$46.49 million (+27.58%) on 30 September 2024. Over the past year, it has increased by +$68.23 million (+46.48%). JAZZ quarterly net income is now -17.89% below its all-time high of $261.90 million, reached on 30 June 2019.JAZZ Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
$463.16 M
+$68.23 M+17.28%
30 September 2024
Summary:
Jazz Pharmaceuticals TTM net profit is currently $463.16 million, with the most recent change of +$68.23 million (+17.28%) on 30 September 2024. Over the past year, it has increased by +$383.20 million (+479.28%). JAZZ TTM net income is now -29.38% below its all-time high of $655.88 million, reached on 30 June 2019.JAZZ TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
JAZZ Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +285.1% | +46.5% | +479.3% |
| 3 y3 years | +73.8% | +507.1% | +387.9% |
| 5 y5 years | -7.2% | +110.3% | -23.9% |
JAZZ Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +225.8% | at high | +189.3% | at high | +203.0% |
| 5 y | 5 years | -20.7% | +225.8% | at high | +159.2% | -23.9% | +203.0% |
| alltime | all time | -20.7% | +225.8% | -17.9% | +159.2% | -29.4% | +203.0% |
Jazz Pharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $215.06 M(+27.6%) | $463.16 M(+17.3%) |
| June 2024 | - | $168.57 M(-1253.2%) | $394.92 M(+19.4%) |
| Mar 2024 | - | -$14.62 M(-115.5%) | $330.79 M(-20.3%) |
| Dec 2023 | $414.83 M(-285.1%) | $94.15 M(-35.9%) | $414.83 M(+418.8%) |
| Sept 2023 | - | $146.82 M(+40.6%) | $79.95 M(-192.4%) |
| June 2023 | - | $104.44 M(+50.4%) | -$86.51 M(-44.6%) |
| Mar 2023 | - | $69.42 M(-128.8%) | -$156.29 M(-30.2%) |
| Dec 2022 | -$224.06 M(-32.0%) | -$240.72 M(+1125.2%) | -$224.06 M(+1099.0%) |
| Sept 2022 | - | -$19.65 M(-156.7%) | -$18.69 M(-64.0%) |
| June 2022 | - | $34.66 M(+2004.7%) | -$51.87 M(-88.5%) |
| Mar 2022 | - | $1.65 M(-104.7%) | -$449.85 M(+36.5%) |
| Dec 2021 | -$329.67 M(-238.2%) | -$35.35 M(-33.1%) | -$329.67 M(+104.9%) |
| Sept 2021 | - | -$52.83 M(-85.5%) | -$160.90 M(-500.6%) |
| June 2021 | - | -$363.32 M(-398.2%) | $40.16 M(-92.3%) |
| Mar 2021 | - | $121.83 M(-8.7%) | $518.28 M(+117.2%) |
| Dec 2020 | $238.62 M(-54.4%) | $133.41 M(-10.0%) | $238.62 M(+33.2%) |
| Sept 2020 | - | $148.23 M(+29.1%) | $179.19 M(+34.5%) |
| June 2020 | - | $114.80 M(-172.7%) | $133.24 M(-52.5%) |
| Mar 2020 | - | -$157.83 M(-313.3%) | $280.33 M(-46.4%) |
| Dec 2019 | $523.37 M(+17.1%) | $73.99 M(-27.7%) | $523.37 M(-14.0%) |
| Sept 2019 | - | $102.28 M(-60.9%) | $608.85 M(-7.2%) |
| June 2019 | - | $261.90 M(+207.4%) | $655.88 M(+34.9%) |
| Mar 2019 | - | $85.20 M(-46.6%) | $486.31 M(+8.8%) |
| Dec 2018 | $447.10 M(-8.4%) | $159.47 M(+6.8%) | $447.10 M(-14.0%) |
| Sept 2018 | - | $149.32 M(+61.7%) | $519.84 M(+19.8%) |
| June 2018 | - | $92.32 M(+100.7%) | $434.05 M(-3.0%) |
| Mar 2018 | - | $45.99 M(-80.2%) | $447.33 M(-8.3%) |
| Dec 2017 | $487.85 M(+22.9%) | $232.21 M(+265.5%) | $487.85 M(+31.0%) |
| Sept 2017 | - | $63.53 M(-39.8%) | $372.33 M(-6.6%) |
| June 2017 | - | $105.60 M(+22.1%) | $398.63 M(-2.2%) |
| Mar 2017 | - | $86.51 M(-25.9%) | $407.53 M(+2.7%) |
| Dec 2016 | $396.83 M(+20.4%) | $116.69 M(+29.9%) | $396.83 M(+9.3%) |
| Sept 2016 | - | $89.83 M(-21.5%) | $362.90 M(+0.5%) |
| June 2016 | - | $114.50 M(+51.0%) | $361.04 M(+7.9%) |
| Mar 2016 | - | $75.81 M(-8.4%) | $334.65 M(+1.6%) |
| Dec 2015 | $329.54 M(+464.4%) | $82.76 M(-5.9%) | $329.54 M(+0.3%) |
| Sept 2015 | - | $87.96 M(-0.2%) | $328.39 M(+23.4%) |
| June 2015 | - | $88.11 M(+24.6%) | $266.19 M(+20.0%) |
| Mar 2015 | - | $70.70 M(-13.4%) | $221.74 M(+279.8%) |
| Dec 2014 | $58.39 M | $81.61 M(+216.7%) | $58.39 M(+82.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2014 | - | $25.77 M(-41.0%) | $32.07 M(-60.8%) |
| June 2014 | - | $43.66 M(-147.1%) | $81.71 M(+1.8%) |
| Mar 2014 | - | -$92.65 M(-267.6%) | $80.24 M(-62.9%) |
| Dec 2013 | $216.31 M(-25.0%) | $55.29 M(-26.7%) | $216.31 M(-40.2%) |
| Sept 2013 | - | $75.41 M(+78.8%) | $361.57 M(+13.2%) |
| June 2013 | - | $42.19 M(-2.9%) | $319.37 M(+4.9%) |
| Mar 2013 | - | $43.42 M(-78.3%) | $304.33 M(+5.5%) |
| Dec 2012 | $288.59 M(+130.9%) | $200.55 M(+503.9%) | $288.59 M(+129.9%) |
| Sept 2012 | - | $33.21 M(+22.3%) | $125.51 M(+0.6%) |
| June 2012 | - | $27.14 M(-1.9%) | $124.78 M(-4.6%) |
| Mar 2012 | - | $27.68 M(-26.1%) | $130.84 M(+4.7%) |
| Dec 2011 | $124.98 M(+281.3%) | $37.47 M(+15.4%) | $124.98 M(+11.6%) |
| Sept 2011 | - | $32.48 M(-2.2%) | $111.97 M(+20.7%) |
| June 2011 | - | $33.20 M(+52.1%) | $92.73 M(+74.5%) |
| Mar 2011 | - | $21.83 M(-10.8%) | $53.14 M(+62.1%) |
| Dec 2010 | $32.78 M(-579.5%) | $24.46 M(+84.7%) | $32.78 M(+134.6%) |
| Sept 2010 | - | $13.24 M(-307.3%) | $13.97 M(-1581.7%) |
| June 2010 | - | -$6.39 M(-536.3%) | -$943.00 K(-112.4%) |
| Mar 2010 | - | $1.46 M(-74.1%) | $7.62 M(-211.4%) |
| Dec 2009 | -$6.84 M(-96.3%) | $5.65 M(-438.1%) | -$6.84 M(-90.2%) |
| Sept 2009 | - | -$1.67 M(-177.0%) | -$69.43 M(-28.1%) |
| June 2009 | - | $2.17 M(-116.7%) | -$96.57 M(-35.9%) |
| Mar 2009 | - | -$12.99 M(-77.2%) | -$150.62 M(-18.3%) |
| Dec 2008 | -$184.34 M(+32.8%) | -$56.94 M(+97.6%) | -$184.34 M(-1.6%) |
| Sept 2008 | - | -$28.81 M(-44.5%) | -$187.42 M(+5.3%) |
| June 2008 | - | -$51.88 M(+11.1%) | -$177.97 M(+7.2%) |
| Mar 2008 | - | -$46.71 M(-22.2%) | -$165.95 M(+19.5%) |
| Dec 2007 | -$138.83 M(+133.7%) | -$60.02 M(+210.0%) | -$138.83 M(+52.3%) |
| Sept 2007 | - | -$19.36 M(-51.4%) | -$91.14 M(+8.3%) |
| June 2007 | - | -$39.86 M(+103.5%) | -$84.12 M(+48.6%) |
| Mar 2007 | - | -$19.58 M(+58.7%) | -$56.59 M(-4.7%) |
| Dec 2006 | -$59.39 M(-30.3%) | -$12.34 M(0.0%) | -$59.39 M(-13.1%) |
| Sept 2006 | - | -$12.34 M(0.0%) | -$68.34 M(-11.6%) |
| June 2006 | - | -$12.34 M(-44.9%) | -$77.29 M(-10.4%) |
| Mar 2006 | - | -$22.38 M(+5.1%) | -$86.25 M(+1.3%) |
| Dec 2005 | -$85.16 M(+243.3%) | -$21.29 M(0.0%) | -$85.16 M(+33.3%) |
| Sept 2005 | - | -$21.29 M(0.0%) | -$63.87 M(+50.0%) |
| June 2005 | - | -$21.29 M(0.0%) | -$42.58 M(+100.0%) |
| Mar 2005 | - | -$21.29 M | -$21.29 M |
| Dec 2004 | -$24.80 M | - | - |
FAQ
- What is Jazz Pharmaceuticals annual net profit?
- What is the all time high annual net income for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals annual net income year-on-year change?
- What is Jazz Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals quarterly net income year-on-year change?
- What is Jazz Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals TTM net income year-on-year change?
What is Jazz Pharmaceuticals annual net profit?
The current annual net income of JAZZ is $414.83 M
What is the all time high annual net income for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high annual net profit is $523.37 M
What is Jazz Pharmaceuticals annual net income year-on-year change?
Over the past year, JAZZ annual net profit has changed by +$638.89 M (+285.14%)
What is Jazz Pharmaceuticals quarterly net profit?
The current quarterly net income of JAZZ is $215.06 M
What is the all time high quarterly net income for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high quarterly net profit is $261.90 M
What is Jazz Pharmaceuticals quarterly net income year-on-year change?
Over the past year, JAZZ quarterly net profit has changed by +$68.23 M (+46.48%)
What is Jazz Pharmaceuticals TTM net profit?
The current TTM net income of JAZZ is $463.16 M
What is the all time high TTM net income for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high TTM net profit is $655.88 M
What is Jazz Pharmaceuticals TTM net income year-on-year change?
Over the past year, JAZZ TTM net profit has changed by +$383.20 M (+479.28%)